文献速递冠心病外科

心脏手术患者手术部位感染的经济负担

Economic burden of surgical site infections in patients undergoing cardiac surgery†.
PubMed 文献 · Eur J Cardiothorac Surg · 2019-01-01

该研究基于耶拿大学医院2013年1月至2014年12月999例连续冠脉搭桥患者数据,分析手术部位感染(SSI)的额外费用与住院时间。共983例纳入分析,126例发生SSI,其中124例(98.4%)存活出院。SSI患者抗菌治疗平均费用为818欧元(95%CI 392-1245),负压伤口治疗平均费用为1179欧元(95%CI 748-1610),SSI所致平均额外住院时间为9.3±2.6天,额外住院时间归因费用为9444欧元(95%CI 4242-14645)。结论认为SSI与额外住院时间和显著经济负担相关,额外费用的重要组成部分是住院时间延长。

要点

  • 冠脉搭桥后SSI患者抗菌治疗平均费用818欧元(95%CI 392-1245)。
  • SSI患者负压伤口治疗平均费用1179欧元(95%CI 748-1610)。
  • SSI所致平均额外住院时间9.3±2.6天,归因费用9444欧元(95%CI 4242-14645)。

核心结论

  • 冠脉搭桥后SSI与额外住院时间和显著经济负担相关,且经济负担取决于SSI分类。
  • 额外费用的一个非常重要的组成部分是住院时间延长,因此尽可能缩短因SSI导致的住院时间至关重要。

研究设计与样本

  • 研究收集了耶拿大学医院2013年1月至2014年12月999例连续接受冠脉搭桥患者的资料。
  • 共983例患者纳入分析,研究期间识别出126例冠脉搭桥后SSI患者。
  • 从医院视角计算SSI相关额外费用,并采用多状态模型评估住院时间延长及相应费用。

主要发现

  • 126例SSI患者中124例(98.4%)存活出院。
  • 治疗SSI的抗菌治疗平均费用为每例感染患者818欧元(95%CI 392-1245)。
  • 负压伤口治疗平均费用为每例感染患者1179欧元(95%CI 748-1610)。
  • SSI所致平均额外住院时间(±标准误)估计为9.3±2.6天。
  • 每例SSI感染患者归因于额外住院时间的费用为9444欧元(95%CI 4242-14645)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study aimed to determine the additional costs and length of stay (LOS) due to surgical site infections (SSIs) after coronary artery bypass grafting (CABG) at Jena University Hospital. METHODS: The data of 999 consecutive patients who underwent CABG from January 2013 to December 2014 were collected. We extracted the number, type and duration of antimicrobial therapy and V.A.C.® therapy (negative pressure wound therapy) treatments and calculated the additional SSI-related costs based on the hospital's perspective. We also evaluated the prolongation of LOS using a multistate model and calculated the costs due to the additional LOS. RESULTS: In total, 983 patients were included in our analysis, and 126 patients with SSIs following CABG were identified during the study period; 124 patients with SSIs (98.4%) were discharged alive. The mean cost of antimicrobial therapy to treat the SSIs was €818 [95% confidence interval (CI) 392-1245], and the mean cost of V.A.C. therapy was €1179 (95% CI 748-1610) per infected patient. The mean additional LOS due to SSIs (±standard error) was estimated to be 9.3 ± 2.6 days. The cost per SSI-infected patient attributable to the additional LOS was €9444 (95% CI 4242-14 645). CONCLUSIONS: SSIs following CABG are associated with an additional LOS and a significant economic burden depending on the classification of SSI. A very important component of the additional cost is the prolongation of LOS. Therefore, it is essential to shorten the hospital stay due to SSIs as far as possible.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Findeisen A, Arefian H, Doenst T, et al. Economic burden of surgical site infections in patients undergoing cardiac surgery†. Eur J Cardiothorac Surg. 2019. PMID: 30084908. doi:10.1093/ejcts/ezy274

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。